Human telomerase reverse transcriptase promoter regulation in normal and malignant human ovarian epithelial cells

Cancer Research

Volumn 61, Issue 14, 2001, Pages 5529-5536

  Braunstein, Ilana ^a   Cohen Barak, Orit ^a,d   Shachaf, Catherine ^a   Ravel, Yael ^b   Yalon Hacohen, Michal ^a   Mills, Gordon B ^c   Tzukerman, Maty ^b   Skorecki, Karl L ^a,b  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^b RAMBAM MEDICAL CENTER   (Israel)

^c UNIVERSITY OF TEXAS   (United States)

^d UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TELOMERASE; TRANSCRIPTION FACTOR;

ARTICLE; BINDING SITE; CELL IMMORTALIZATION; CONTROLLED STUDY; DNA PROTEIN COMPLEX; ENZYME ACTIVITY; EPITHELIUM CELL; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; OVARY CANCER; OVARY TUMOR; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SITE DIRECTED MUTAGENESIS; SOMATIC CELL; TRANSCRIPTION REGULATION;

BASE SEQUENCE; BINDING SITES; BINDING, COMPETITIVE; CELL LINE; DNA, NEOPLASM; DNA-BINDING PROTEINS; EPITHELIAL CELLS; FEMALE; GENE EXPRESSION REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUCIFERASES; MUTATION; OLIGONUCLEOTIDES; OVARIAN NEOPLASMS; PROMOTER REGIONS (GENETICS); RECOMBINANT FUSION PROTEINS; REGULATORY SEQUENCES, NUCLEIC ACID; RNA; TELOMERASE; TUMOR CELLS, CULTURED;

EID: 0035878797     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Chromosome first aid
2. Identification of a specific telomere terminal transferase activity in Tetrahymena extracts
3. Telomeres shorten during aging of human fibroblasts
4. Telomerase activity in human germline and embryonic tissues and cells
5. Evidence for a mitotic clock in human hematopoietic stem cells: Loss of telomeric DNA with age
6. Specific association of human telomerase activity with immortal cells and cancer
7. Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity
8. The RNA component of human telomerase
9. Human telomerase RNA and telomerase activity in immortal cell lines and tumor tissues
10. Isolation of a candidate human telomerase catalytic subunit gene, which reveals complex splicing patterns in different cell types
11. hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization
12. Expression of human telomerase subunits and correlation with telomerase activity in cervical cancer
13. Expression of TERT in early premalignant lesions and a subset of cells in normal tissues
14. Expression profile of the putative catalytic subunit of the telomerase gene
15. hTERT is a critical determinant of telomerase activity in renal-cell carcinoma
16. Reconstitution of human telomerase with the template RNA component hTR and the catalytic protein subunit hTRT
17. Telomerase activity is restored in human cells by ectopic expression of hTERT (hEST2), the catalytic subunit of telomerase
18. Extension of life-span by introduction of telomerase into normal human cells
19. The human telomerase catalytic subunit hTERT: Organization of the gene and characterization of the promoter
20. Cloning of human telomerase catalytic subunit (hTERT) gene promoter and identification of proximal core promoter sequences essential for transcriptional activation in immortalized and cancer cells
21. Cloning and characterization of the promoter region of human telomerase reverse transcriptase gene
22. Direct activation of TERT transcription by c-MYC
23. Genomic organization and promoter characterization of the gene encoding the human telomerase reverse transcriptase (hTERT)
24. Identification of a novel transcription factor binding element involved in the regulation by differentiation of the human telomerase (hTERT) promoter
25. Proteins of the Myc network: Essential regulators of cell growth and differentiation
26. Myc activates telomerase
27. In vivo and in vitro analyses of Myc for differential promoter activities of the human telomerase (hTERT) gene in normal and tumor cells
28. Telomerase reverse transcriptase gene is a direct target of c-Myc but is not functionally equivalent in cellular transformation
29. Spl cooperates with c-Myc to activate transcription of the human telomerase reverse transcriptase gene (hTERT)
30. Expression of human telomerase subunits in ovarian malignant, borderline and benign tumors
31. Telomerase activity in human ovarian carcinoma
32. Telomerase activity in ovarian tumors
33. Comparative properties of five human ovarian adenocarcinoma cell lines
34. Characterization of cultured human ovarian surface epithelial cells: Phenotypic plasticity and premalignant changes
35. Rapid detection of octamer binding proteins with "mini-extracts", prepared from a small number of cells
36. Evidence for an alternative mechanism for maintaining telomere length in human tumors and tumor-derived cell lines
37. The molecular basis of ovarian cancer
38. Applications of telomerase research in the fight against cancer
39. A survey of telomerase activity in human cancer
40. Differential telomerase activity, expression of the telomerase catalytic subunit and telomerase-RNA in ovarian tumors
41. Telomerase activity correlates with tumor aggressiveness and reflects therapy effect in breast cancer
42. Telomerase expression in human breast cancer with and without lymph node metastases
43. Telomerase catalytic subunit homologs from fission yeast and human
44. Regulation of telomerase by alternate splicing of human telomerase reverse transcriptase (hTERT) in normal and neoplastic ovary, endometrium and myometrium
45. Characterization of a human ovarian carcinoma cell line (NIH:OVCAR-3) with androgen and estrogen receptors
46. Activation of the ras-mitogen-activated protein kinase pathway and phosphorylation of ets-2 at position threonine 72 in human ovarian cancer cell lines
47. MMAC1/PTEN mutations in primary tumor specimens and tumor cell lines
48. Adenovirus-mediated p53 growth inhibition of ovarian cancer cells is independent of endogenous p53 status
49. Expression of p16 induces transcriptional downregulation of the RB gene
50. PIK3CA is implicated as an oncogene in ovarian cancer